• Views: in the last
  • 38Week
  • 22Month
  • 275Total


  • NJ S2156
  • Requires prescribers to discuss addiction risk associated with certain drugs prior to issuing prescription to minor patient.
Introduced
(5/5/2016)
In Committee
(12/5/2016)
Crossed Over
(10/20/2016)
Passed
(12/19/2016)
Signed
(2/6/2017)
Dead/Failed/Vetoed
2016-2017 Regular Session
This bill requires health care professionals with prescribing authority to discuss the addiction potential of certain prescription medications prior to issuing a prescription for the medication to a patient who is under 18 years of age. The prescriber is to have this discussion with the patient, if the patient is an emancipated minor, and with the patient's parent or guardian if the patient is not emancipated. The discussion will be required prior to issuing a prescription for any Schedule II controlled dangerous substance and any medication which is a prescription opioid. The prescriber will specifically be required to discuss the risks of developing a physical or psychological dependence on the medication and, if the prescriber deems it appropriate, any alternative treatments that may be available. The prescriber will be required to obtain a written acknowledgement of the discussion using a form to be developed by the Director of the Division of Consumer Affairs in the Department of Law and Public Safety and to include this written acknowledgement in the patient's medical file. The director will additionally be required to develop, and make available to prescribers, guidelines for the discussion required under the bill. The bill does not require the discussion when prescribing medication to patients who are under hospice care.
2nd Reading in the Assembly, 2nd Reading in the Senate, Bills and Joint Resolutions Signed by the Governor, Budget and Appropriations, Health and Senior Services, Health, Human Services and Senior Citizens, Passed both Houses, Passed Senate
Approved P.L.2017, c.8.  (on 2/6/2017)
 
 
Date Chamber Action Description
2/6/2017 A Approved P.L.2017, c.8.
12/19/2016 A Passed Assembly (Passed Both Houses) (77-0-0)
12/19/2016 A Substituted for A3424 (1R)
12/5/2016 A Reported out of Assembly Committee, 2nd Reading
12/5/2016 Assembly Health and Senior Services Hearing (10:00 12/5/2016 Committee Room 11, 4th Floor)
10/20/2016 A Received in the Assembly, Referred to Assembly Health and Senior Services Committee
10/20/2016 S Passed by the Senate (35-1)
10/13/2016 S Reported from Senate Committee, 2nd Reading
10/13/2016 Senate Budget and Appropriations Hearing (11:00 10/13/2016 Committee Room 4, 1st Floor)
9/8/2016 S Referred to Senate Budget and Appropriations Committee
9/8/2016 S Reported from Senate Committee with Amendments, 2nd Reading
9/8/2016 Senate Health, Human Services and Senior Citizens Hearing (13:00 9/8/2016 Committee Room 1, 1st Floor)
5/5/2016 S Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Date Motion Yea Nay Other
Detail 12/19/2016 Assembly Floor: Third Reading - Final Passage 77 0 3
Detail 12/19/2016 Assembly Floor: Substitute For A3424 Aca (Voice Vote) 0 0 0
Detail 12/5/2016 Assembly Health and Senior Services Committee: Reported Favorably 13 0 0
Detail 10/20/2016 Senate Floor: Third Reading - Final Passage 35 1 4
Detail 10/13/2016 Senate Budget and Appropriations Committee: Reported Favorably 13 0 0
Detail 9/8/2016 Senate Health, Human Services and Senior Citizens Committee: Reported with Amendments 8 0 1